Maravai LifeSciences Announces November 2026 Investor Conference Schedule
Maravai LifeSciences (MRVI) is scheduled to participate in investor conference fireside chats on November 12 and November 17, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
On November 12, 2026, at 10:40 a.m. EST, Raj Asarpota, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Stifel Healthcare Conference in
On November 17, 2026, at 4:00 p.m. GMT, Raj Asarpota, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Jefferies Healthcare Conference in
A live webcast of each presentation will be available to all interested parties on the Maravai LifeSciences Investor Relations website, under News & Events, IR Calendar. An archived version of the webcast will also be available on the Maravai website after the event is completed.
About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world’s leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapies companies.
For more information about Maravai LifeSciences, visit www.maravai.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20261029937964/en/
Investor Contact:
Deb Hart
Maravai LifeSciences
+1 858-988-5917
ir@maravai.com
Source: Maravai LifeSciences, Inc.